{"id":"W4417012988","doi":"10.1182/blood-2025-4988","title":"Study design of A phase 3, open-label trial for pozelimab and cemdisiran combination therapy in patients with paroxysmal nocturnal hemoglobinuria with inadequate control of intravascular hemolysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Eculizumab; Hemolysis; Combination therapy; Hemolytic anemia; Complement membrane attack complex; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004403825,0.0001645624,0.0005691972,0.0001574362,0.00006488259,0.00001676621,0.0002264155,0.0000584644,0.00001609454],"category_scores_gemma":[0.00004970043,0.0001196096,0.00002900432,0.0001953561,0.00009357281,0.00008103784,0.00004091868,0.00006586919,2.440352e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001676786,"about_ca_system_score_gemma":0.0001132017,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008721016,"about_ca_topic_score_gemma":0.0000276482,"domain_scores_codex":[0.9985959,0.0004313807,0.0004663967,0.0002610087,0.00006650164,0.0001788059],"domain_scores_gemma":[0.9990797,0.0002122899,0.0002810653,0.0002365304,0.0001761052,0.00001430757],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.551148,0.1052421,0.3120976,0.0001998895,0.006909692,0.000006740328,0.001319394,0.00004706101,0.01382554,0.000405556,0.00005940138,0.008739076],"study_design_scores_gemma":[0.9227504,0.02759445,0.03847396,0.0001177366,0.0007417229,0.000001436131,0.0003520043,0.00002514007,0.009703055,0.00008584135,0.000008854965,0.000145429],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900345,0.0005295598,0.002394036,0.00002464455,0.00005526684,0.006846376,0.0001004957,0.000007863728,0.000007292829],"genre_scores_gemma":[0.9993625,0.000004898758,0.0001476283,0.00001852192,0.00000352054,0.0003806913,0.00005824952,0.00001036703,0.00001363203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3716024,"threshold_uncertainty_score":0.4877537,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02517642764675572,"score_gpt":0.2888051443544865,"score_spread":0.2636287167077307,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}